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A B S T R A C T
Objective: To assess selection criteria for temporal lobectomy and to evaluate the process for pre-surgical
evaluation, informed consent, and the deﬁnition of success.
Methods: We constructed an electronic survey instrument composed of 26 questions and sent it to
epileptologists and neurosurgeons at 105 US epilepsy centers.
Results: While variation with the number of drug failures that signify pharmacoresistance and surgical
candidacy exists, there does appear to be a consensus. The deﬁnition of a successful surgery also varies.
Furthermore, physicians differ with regard to appropriate preoperative tests that determine surgical
candidacy and may predict surgical outcome. The informed consent process provided is thorough for
some aspects of surgery and incomplete for other signiﬁcant aspects.
Conclusion: The data show that the neurological community currently does not have consistent
deﬁnitions and practices in the management of pharmacoresistant epilepsy. Therefore, there appears to
be need for developing a uniﬁed approach.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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One-third of patients with temporal lobe epilepsy experience
refractory and pharmacoresistant seizures.1 To attain seizure
control, many of these patients are being referred for surgical
interventions such as temporal lobectomy (TL). In addition to
providing some patients with a reduced-seizure frequency and
some patients with a seizure-free life, this procedure improves
quality of life. Patients frequently experience positive changes
with employment, social status, and life-expanding privileges,
some as basic as operating a motor vehicle.2 As beneﬁcial as this
surgical procedure appears to be, however, there are complications
and associated risks that could offset these beneﬁts or create new
problems.
The success rate of TL declines from approximately 80% to nearly
50% over a decade.3 Regardless of its effectiveness in eliminating
seizures, left TLmay cause verbalmemory deﬁcits4 and right TLmay
cause visuospatial memory deﬁcits.5 Psychiatric difﬁculties such as
mania, depression, and anxiety can potentially arise in the
immediate post-surgical months,6–10 causing suicide to be a* Corresponding author. Tel.: +1 518 262 6082; fax: +1 518 262 6856.
E-mail addresses: demased@hotmail.com (D.F. DeMase),
gruentm@mail.amc.edu (M. Gruenthal), balintj@mail.amc.edu (J. Balint).
c Tel.: +1 518 262 5226.
d Tel.: +1 518 262 6082; fax: +1 518 262 6856.
1059-1311/$ – see front matter  2009 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.10.005concern.11 Neurological deﬁcits ranging from visual impairments
to hemiparesis to dysphasia are other possible complications.12
Because the risks and burdens of the procedure may outweigh
the beneﬁts, providing patients with appropriate preoperative
counseling and informed consent is necessary. After reviewing the
questions, concerns, and comments posted on the eCommunities
forum,b we hypothesized that the caliber of the informed consent
process and preoperative counseling provided to patients con-
sidering temporal lobectomy may be inadequate in some cases.
Using the phrases ‘‘temporal lobectomy and preoperative counsel-
ing,’’ ‘‘temporal lobe resection and preoperative counseling,’’
‘‘temporal lobectomy and informed consent,’’ and ‘‘temporal lobe
resection and informed consent,’’ while conducting a literature
search on Google, Pubmed, and Yahoo, did not identify any studies
that have addressed the informed consent process and preopera-
tive counseling that patients receive before and after being
identiﬁed as surgical candidates. A similar search using the
phrases ‘‘temporal lobectomy and successful outcome’’ and
‘‘temporal lobe resection and successful outcome’’ provided
literature that related to a successful outcome in terms of quality
of life. There appeared to be no consensus regarding what
constitutes success as a function of time after surgery. In an effort
to identify variations in the criteria for the selection of surgicalb The eCommunities forum is provided by the American Epilepsy Foundation and
can be located at www.epilepsyfoundation.org.
vier Ltd. All rights reserved.
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and assessment of what constitutes a successful surgery, we
assessed the practices, attitudes, and beliefs of US epileptologists
and neurosurgeons.
2. Methods
Data were gathered via the electronic survey instrument
SurveyMonkeyTM. After a survey was constructed on www.
surveymonkey.com and approved by the Institutional Review
Board of AlbanyMedical College, an email describing the study and
containing a link to the survey was sent to physicians at 105 US
epilepsy centers. Epileptologists and neurosurgeons from epilepsy
centers that provided webpage information in the National
Association of Epilepsy Centers Membership (NAEC) 2006 Direc-
tory constituted approximately 95% of the sample. Additional
epileptologists and neurosurgeons were included in the sample
after doing an internet search. E-mail addresses were acquired
from internet sources. Follow-up emails were sent out twice in
two-week intervals. Responses were anonymous, and as surveys
were completed, data were incorporated into a data pool. No
personal identiﬁers were provided, and the implementation of the
survey ensured that each physician could only participate once.
The Albany Medical Center Comprehensive Epilepsy Center was
excluded from this study, since this study originated from this
institution.
The sample originally included 371 physicians—169 adult
epileptologists, 82 pediatric epileptologists, 67 adult neurosur-
geons, and 53 pediatric neurosurgeons. The ﬁnal sample included
333 physicians, because 38 physicians had to be removed from the
sample for reasons such as emails failing to send, physicians
stating that they were not qualiﬁed enough to participate, and
difﬁculty accessing the link to the survey. The overall response rate
for the survey was 32.4% (108/333). The individual response rates
were 38.2% (60/157) for adult epileptologists, 16.4% (11/67) for
pediatric epileptologists, 30.6% (19/62) for adult neurosurgeons,
and 39.1% (18/46) for pediatric neurosurgeons. The response rate
for each question varied. Furthermore, because the sample pool of
adult epileptologists in the study is greater than that of the
pediatric epileptologists, the results from adult epileptologists
may be considered more valid. However, the trends, similarities,
and differences observed between both populations will be
discussed.
3. Results
3.1. Pharmacoresistance and surgical candidacy
Approximately 80% (78/98) of physicians decided on or
estimated the minimum number of antiepileptic drug (AED)
failures that deﬁne pharmacoresistance and surgical candidacy.
The remaining 20% (20/98) of the physicians, however, indicated
that there are no minimum number of AED failures that deﬁne
pharmacoresistance and surgical candidacy. Table 1 summarizes
these data.Table 1
Number of antiepileptic drug failures that deﬁne pharmacoresistance and surgical can
No. of survey respondents No. of respondents who
responded to question
0
AEP 60 53 1
ANS 19 19 1
PEP 11 10a 1
PNS 18 16 4
AEDF: AED failure, ANS: adult neurosurgeon, PNS: pediatric neurosurgeon, AEP: adult
a All survey respondents responded to this question, but the following response wasThe number of AED failures that deﬁne pharmacoresistance
varied widely among both epileptologists and neurosurgeons.
However, a general consensus did exist between adult epileptol-
ogists and adult neurosurgeons, inasmuch as the majority of
physicians in each of these groups correlated two drug failures
with refractory seizures and criteria for surgical candidacy. A
similar trend was observed with pediatric epileptologists. Differ-
ences were noted, however, among pediatric neurosurgeons, since
43.4% (7/16) of these physicians did not associate a minimum
number of drug failures with intractable seizures, while 25% (4/16)
of them felt that at least two ormore drugs needed to be attempted
before TL could be considered as a treatment option.
3.2. The role of preoperative examinations with preoperative
counseling and surgical candidacy
A battery of examinations is available to identify ideal surgical
candidates, allow informed consent to be provided, and predict TL
efﬁcacy, especially for adult patients in whom language and
memory dominance has been lateralized. TheWada test appears to
be the most common preoperative examination conducted on
adult patients to identify the dominant hemisphere. As Table 2
indicates, 52% (26/50) of adult epileptologists and 64.7% (11/17) of
adult neurosurgeons deemed the Wada test essential. All adult
neurosurgeons and 98% (55/56) of adult epileptologists stated that
it is a test available at their institution. Some physicians, especially
adult epileptologists, routinely conduct this exam on all patients
prior to surgery. Approximately 32.1% (18/56) of adult epileptol-
ogists and 15.8% (3/19) of adult neurosurgeons listed only the
Wada test as the preferred exam to evaluate hemisphere
dominance.
Despite appearing as the ‘‘gold standard’’ exam, as one
participant described it, 10.1% (6/56) of adult epileptologists
stated that only left-handed persons, right-handed persons who
present with a normal MRI, and/or patients who are suspected to
have a dominant right hemisphere qualify for the Wada test.
Patients who are right-handed are often assumed to be left
hemisphere dominant and are not offered this preoperative
examination. Furthermore, some adult epileptologists noted that
the Wada test is offered only if there is doubt from the results of
other dominant hemisphere-detecting examinations, especially
the neuropsychological evaluation.
The majority of pediatric epileptologists and pediatric neuro-
surgeons viewed the Wada test as important, but not essential
(Table 2). Furthermore, handedness and the results of MRIs were
not regarded as factors that determine eligibility for theWada test,
as they often were for adult patients. Age appears to be a critical
determinant of whether the dominant hemisphere-identifying
procedure will be offered to patients of the pediatric population.
While some pediatric neurosurgeons expressed interest in
conducting the Wada test on all patients, some only offer this
preoperative test to ‘‘older’’ pediatric patients. The deﬁnition of
‘‘older,’’ however, varied inasmuch as one epileptologist deﬁned it
as seven years of age, and a neurosurgeon deﬁned it as ‘‘beyond a
mental age of 12 or 13 years.’’ It did appear, however, that upondidacy.
AEDF 1 AEDF 2 AEDFs 2 AEDFs
7% (9/53) 1.9% (9/53) 54.7% (29/53) 26.4% (14/53)
5.8% (3/19) 5.3% (3/19) 63.2% (12/19) 15.8% (3/19)
0% (1/10) 0% 80% (8/10) 10% (1/10)
3.4% (7/16) 0% 31.3% (5/16) 25% (4/16)
epileptologist, PEP: pediatric epileptologist, and 2 AEDFs: at least two or more.
excluded: ‘‘<3 AEDs’’.
Table 2
Importance of the Wada test to identify hemisphere dominance.
No. of survey respondents No. of respondents who responded to question 1 (unessential) 2 3 4 (essential)
AEP 60 50 2% (1/50) 20% (10/50) 26% (13/50) 52% (26/50)
ANS 19 17 0% 17.6% (3/17) 17.6% (3/17) 64.7% (11/17)
PEP 11 10 0% 0% 60% (6/10) 40% (4/10)
PNS 18 15 6.7% (1/15) 6.7% (1/15) 60% (9/15) 26.7% (4/15)
AEP: adult epileptologist, ANS: adult neurosurgeon, PEP: pediatric epileptologist, and PNS: pediatric neurosurgeon.
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sphere-identifying tests are preferred at many institutions. Nearly
all physicians stated that they inform patients that neuropsycho-
logical deﬁcits can develop after surgery. However, only 32.1%
(18/56) of adult epileptologists, 36.8% (7/19) of adult neurosur-
geons, 45.5% (5/11) of pediatric epileptologists, and 56.3% (9/16) of
pediatric neurosurgeons stated that they conduct a neuropsycho-
logical evaluation prior to surgery. The majority of physicians who
use this combined language and memory evaluation do so in
conjunction with other preoperative tests. It is evident, however,
that this dominant hemisphere-identifying test is not always
available, since one adult neurosurgeon stated that it is used
‘‘when it can be obtained.’’ According to the same respondent, this
preoperative test is often not covered by insurance.
Functional magnetic resonance imaging (fMRI), a non-invasive
procedure that can show agreement with the Wada test in
language only, seems to be used by 28.6% (15/56) of adult
epileptologists, 36.8% (7/19) of adult neurosurgeons, 72.7% (8/11)
of pediatric epileptologists, and 62.5% (10/16) of pediatric
neurosurgeons. This preoperative procedure is routinely per-
formed at some epilepsy centers and selectively offered at other
epilepsy centers. When it is offered, it is often carried out in
combination with other preoperative tests, including the Wada
test and/or magnetoencephalography (MEG). Some respondents
noted that it is used to corroborate the ﬁndings of other dominant
hemisphere-identifying procedures. Some physicians stated that
the exam is not offered simply because it is unavailable. One adult
epileptologist stated that he/she does not offer the fMRI, because
he/she does not ﬁnd the information provided by this exam to be
speciﬁc.
MEG, a non-invasive procedure, locates language hemispheric
dominance and has been identiﬁed as an alternative to the Wada
test.13 A greater proportion of pediatric epileptologists (6/11)
expressed interest in this exam than adult epileptologists (5/56).
Despite being an alternative to the Wada test, MEG is frequently
carried out in conjunction with the Wada test since, as expressed
by a pediatric epileptologist, ‘‘The Wada test offers memory
evaluation.’’ An adult neurosurgeon noted, however, that MEG ‘‘is
used for spike detection, and language mapping is not relied on for
surgical decisions.’’ Furthermore, as previously mentioned, fMRI is
another exam that institutions perform along with MEG. However,Table 3
Importance of the PET and SPECT scans to identify epileptogenic regions.
Fraction of survey respondents
who responded to question
Exam 1 (unimporta
AEP 50/60 PET 4% (2/50)
50/60 SPECT 36% (18/50)
ANS 16/19 PET 6.3% (1/16)
17/19 SPECT 11.8% (2/17)
PEP 10/11 PET 0%
10/11 SPECT 10% (1/10)
PNS 16/18 PET 12.5% (2/16)
15/18 SPECT 13.3% (2/15)
AEP: adult epileptologist, ANS: adult neurosurgeon, PEP: pediatric epileptologist, and Pas some respondents notedwith other exams, MEG is not routinely
offered as a result of the lack of insurance coverage.
In addition to dominant hemisphere-identifying exams, epi-
leptogenic region-locating tests are important for determining
surgical candidacy. In addition to conventional electroencephalo-
graphic methods, positron emission tomography (PET) and single-
photon emission computed tomography (SPECT) are two common
examples. As Table 3 indicates, there is considerable variation
within the ranking of importance of these exams. It does appear
that PET scans are favored more than SPECT scans by the majority
of epileptologists and adult neurosurgeons. Pediatric neurosur-
geons, however, appear to value SPECT scans more than PET scans
(Table 3).
3.3. Preoperative counseling and informed consent
A signiﬁcant fraction of physicians identiﬁed seizure outcome
as one of the most signiﬁcant topics for preoperative discussion. It
appears that 83.7% (41/49) of adult epileptologists and 82.4%
(14/17) of adult neurosurgeons provide patients with detailed
information regarding the likelihood of postoperative freedom
from seizures. They discuss the short-term success, as well as the
long-term success of resection. Providing this complete informa-
tion ‘‘assists with decision making’’ according to some physicians
and ‘‘avoids malpractice’’ claims another physician. However,
16.3% (8/49) of adult epileptologists and 17.6% (3/17) of adult
neurosurgeons focus predominantly on the short-term outcome
and fail to disclose declining success rates commonly seen in the
long-term. An adult epileptologist stated, ‘‘Presenting the long-
term data may dissuade some patients from undergoing surgery.’’
While 69.5% (41/59) of adult epileptologists and adult
neurosurgeons focused solely on the freedom from seizures as
one of the top three most positive outcomes to convey to patients,
nearly 19% (11/59) of the physicians treating adults collectively
considered both the freedom from seizures and the reduction of
seizures as one of the top threemost positive outcomes that should
be conveyed (Table 5). In contrast, approximately 41% (9/22) of
pediatric epileptologists and pediatric neurosurgeons collectively
ranked both freedom from seizures and reduction of seizure
frequency in the top three positive outcomes of TL (Table 5). Seven
out of 22 pediatric epileptologists and pediatric neurosurgeonsnt) 2 3 4 (highly important)
44% (22/50) 36% (18/50) 16% (8/50)
44% (22/50) 18% (9/50) 2% (1/50)
37.5% (6/16) 37.5% (6/16) 18.8% (3/16)
47.1% (8/17) 29.4%(5/17) 11.8% (2/17)
50% (5/10) 20% (2/10) 30% (3/10)
50% (5/10) 40% (4/10) 0%
56.3% (9/16) 6.3% (1/16) 25% (4/16)
40% (6/15) 46.7% (7/15) 0%
NS: pediatric neurosurgeon.
Table 4
Signiﬁcant topics for preoperative discussion.
AEP ANS PEP PNS
No. of survey respondents 60 19 11 18
No. of survey respondents who responded to question 11 49 16 10 15
Preoperative exams results and surgical candidacy 10.2% (5/49) 6.3% (1/16) 20% (2/10) 6.7% (1/15)
Alternative options 8.1% (4/49) 18.8% (3/16) 20% (2/10) 33.3% (5/15)
Beneﬁts and expectationsa 22.4% (11/49) 37.5% (6/16) 50% (5/10) 40% (6/15)
Risks/complicationsb (generic) 49% (24/49) 75% (12/16) 80% (8/10) 93.3% (14/15)
Acute risksc 16.3% (8/49) 25% (4/16) 0% 6.7% (1/15)
Seizure outcome 67.3% (33/49) 37.5% (6/16) 50% (5/10) 46.7% (7/15)
Postoperative AED management 63.3% (31/49) 12.5% (2/16) 50% (5/10) 0%
QOL/psychosocial outcomed 18.4% (9/49) 6.3% (1/16) 60% (6/10) 13.3% (2/15)
Memory/cognitione 32.7% (16/49) 18.8% (3/16) 10% (1/10) 20% (3/15)
Psychiatric issuesf 16.3% (8/49) 12.5% (2/16) 0% 6.7% (1/15)
Language skillsg 22.4% (11/49) 6.3% (1/16) 10% (1/10) 0%
Neurologic deﬁcitsh 57% (28/49) 25% (4/16) 10% (1/10) 20% (3/15)
Hospital stay and recovery 12.2% (6/49) 31.3% (5/16) 10% (1/10) 0%
AEP: adult epileptologist, ANS: adult neurosurgeon, PEP: pediatric epileptologist, and PNS: pediatric neurosurgeon.
a Includes responses such as ‘‘beneﬁts,’’ ‘‘expectations,’’ ‘‘success,’’ and ‘‘outcome’’.
b Includes responses such as ‘‘risks,’’ ‘‘complications,’’ ‘‘risks of surgery,’’ ‘‘surgical risks,’’ ‘‘surgical complications,’’ operative risks,’’ and ‘‘limitations’’.
c Includes responses such as ‘‘bleeding,’’ ‘‘clot,’’ ‘‘CVA,’’ ‘‘death,’’ ‘‘headache,’’ ‘‘hematoma,’’ ‘‘infection,’’ ‘‘nausea,’’ and ‘‘pain’’.
d Includes responses such as ‘‘QOL,’’ ‘‘psychosocial changes,’’ ‘‘driving,’’ ‘‘education,’’ ‘‘employment,’’ ‘‘independence,’’ and ‘‘social changes’’.
e Includes responses such as ‘‘memory,’’ ‘‘cognition’’ and ‘‘neuropsychochological changes’’.
f Includes responses such as ‘‘psychiatric issues,’’ ‘‘psychiatric morbidity,’’ ‘‘neuropsychological changes,’’ ‘‘behavior,’’ ‘‘depression,’’ and ‘‘emotions’’.
g Includes responses such as ‘‘language,’’ ‘‘aphasia,’’ and ‘‘verbal’’.
h Includes responses such as ‘‘neurologic deﬁcits,’’ ‘‘visual deﬁcits,’’ ‘‘memory,’’ ‘‘cognition,’’ ‘‘psychiatric morbidity,’’ ‘‘language skills,’’ ‘‘hemiparesis,’’ ‘‘hemiplegia,’’ and
‘‘quadrantanopsia’’.
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convey (Table 5).
All groups highlighted the importance of patients under-
standing that resection does not guarantee the freedom from
seizures or reduction of seizures (Table 6). However, it is evident
that the adult epileptologists and adult neurosurgeons viewed
freedom from seizures as a more signiﬁcant outcome to convey
than the fact that seizuresmay fail to respond to the surgery.While
71.7% (33/46) of adult epileptologist and 61.5% (8/13) of adult
neurosurgeons focused on the freedom from seizures as a
signiﬁcant positive outcome to convey, only 41.3% (19/46) of
adult epileptologists and 35.7% (5/14) of adult neurosurgeons
viewed post-surgical seizure continuation as a signiﬁcant adverse
outcome to disclose to patients (Tables 5 and 6). Physicians
treating the pediatric population demonstrated the opposite trend
(Tables 5 and 6).
Furthermore, 81.8% (45/55) of epileptologists and 53.8% (14/26)
of neurosurgeons viewed an improved quality of life as one of the
top three most positive outcomes of TL which should be conveyed
to patients (Table 5). The ability to drive, socialize, and gain
education, employment, and independence appear to be the
primary andmost positive outcomes that correlate to an improved
quality of life according to these physicians (Table 4). While the
freedom from seizures does contribute to an improved quality of
life, and the majority of physicians in all groups viewed quality of
life (deﬁned as operating a motor vehicle, acquiring an education,
maintaining employment, and forming stable relationships) to be
as important as the eradication of seizures, 22.9% (11/48) of adult
epileptologists, 20% (3/15) of adult neurosurgeons, and 35.7%
(5/14) of pediatric neurosurgeons believed that seizure eradication
was more important than quality of life. Thirty percent (3/10) of
pediatric epileptologists considered seizure eradication to be less
important.
The importance of the use of AEDs after surgery is incorporated
into preoperative discussions. However, there is nearly a tenfold
difference in the frequency that participating epileptologists and
participating neurosurgeons focused on this topic, inasmuch as
61% (36/59) of responding epileptologists regarded it as one of the
four most signiﬁcant topics to discuss preoperatively in compar-
ison to 6.4% (2/31) of responding neurosurgeons (Table 4).
Furthermore, the reduction of AEDs is a potential positive outcomeof TL discussedwith patients prior to surgerymore frequently than
the discontinuation of AEDs. One epileptologist noted that during
the preoperative, counseling, patients should be made aware that
the goal of TL is to ‘‘stop seizures not medication.’’ Instead of
discussing actual success rates of living a postoperative seizure-
free life, some adult epileptologists and adult neurosurgeons
simply discuss the relationship between freedom from seizures
and the use of AEDs postoperatively. Regardless, 53.2% (25/47) of
adult epileptologists noted that the postoperative requirement of
AEDs is one of the most common misunderstandings that patients
who have undergone TL seem to have.
Risks and complications were stated to be the most signiﬁcant
topic for preoperative discussion by themajority of most groups of
physicians (Table 4). Since these responses were so general, it was
unclear if the physicians were focusing on the short-term
complications or chronic complications. However, it was evident
that a general consensus existed among physicians regarding the
most adverse outcomes of TLwhich patients should bemade aware
of prior to undergoing surgery. The majority of each group
classiﬁed memory and cognitive deﬁcits as one of the top three
adverse outcomes of TL (Table 6). Furthermore, most of the
epileptologists and adult neurosurgeons identiﬁed deﬁcits of this
type as the most adverse outcome. Moreover, while the
epileptologists ranked language and speech deﬁcits as the second
most adverse outcome to be relayed, the neurosurgeons believed it
was as important to disclose potential postoperative visual deﬁcits
(Table 6). Adult neurosurgeons considered neurological deﬁcits
such as hemiplegia or hemiparesis after TL as equally adverse as
the possibility of seizures failing to respond to the surgical
procedure. Adult epileptologists, however, did not prioritize these
neurological deﬁcits as adverse outcomes which should be
conveyed to patients (Table 6).
Alternate options, such as the vagus nerve stimulator and
different AEDs, are approximately twice as likely to be discussed by
adult neurosurgeons with patients prior to surgery than by adult
epileptologists. Additionally, adult neurosurgeons are more likely
than adult epileptologists to discuss the acute complications of
surgery, as well as the hospitalization and recovery process. They
are also more likely than adult epileptologists to focus on
neurological deﬁcits that can arise due to damage directly
associated with the surgical process and which have no relation
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damage to the visual pathways, are twice as likely to be conveyed
to patients by the adult neurosurgeons than adult epileptologists
(Table 6). The same trend was observed for the physicians treating
the pediatric population (Table 6).
3.4. Efﬁcacy of temporal lobectomy on seizure control
A lack of consensus regarding the interval of seizure freedom
that deﬁnes surgical success existed between some physicians. To
some degree, adult epileptologists appear to be more demanding
and have greater expectations than adult neurosurgeons. While
40.7% (22/54) of adult epileptologists identify successful TL as a
procedure that allows a patient to experience no seizures for a
minimum of ﬁve years, 44.4% (8/18) of adult neurosurgeons deem
a procedure successful if seizures are absent for at least one year.
However, the proportion of these physicianswho associate lifetime
seizure eradication with effective temporal lobectomy is basically
equivalent.
Conversely, there was more consensus between pediatric
epileptologists and pediatric neurosurgeons. Seventy percent
(7/10) of pediatric epileptologists and 41.2% (7/17) of pediatric
neurosurgeons correlated a ﬁve year seizure-free time period with
surgical success. Furthermore, like adult neurosurgeons, pediatric
neurosurgeons were more likely to relate permanent remission
with effective resection.
Some physicians, however, have different opinions of what
deﬁnes surgical success, such that they do not focus on a speciﬁc
time period or exclusively on the complete eradication of seizures.
Approximately 3.7% (2/54) of adult epileptologists and 5.1% (1/18)
of adult neurosurgeons expressed more concern regarding the
quality of life and factors such as the severity of seizures, drug load,
and lifestyle changes.
3.5. Limitations
The sample pool of adult epileptologists is greater than that of
pediatric epileptologists. For this reason, the results of adult
epileptologists may be considered more valid. Furthermore, the
practices, viewpoints, and attitudes of the recipients who failed to
respond are unknown. Additionally, the geographic distribution of
the survey recipients who responded and failed to respond is
unknown.
4. Discussion
4.1. Pharmacoresistance and surgical candidacy
While drug therapy controls the seizures of two-thirds of
patients with epilepsy, the number of drugs that must be
attempted and which will be successful vary from patient to
patient. Approximately 47% of patients with epilepsy are
controlled with the ﬁrst prescribed AED.1 When the ﬁrst drug
fails, the chances of responding to a second drug are less than 15%.1
If the second drug fails, additional drug therapy has less than a 5%
chance of controlling seizures.1
Between the established AEDs and the newer AEDs introduced
to the market in the 1990s, there are currently more than 15 AEDs
available. Using each as monotherapy or in combination could
result in 120 different possible treatments.14 Since the lifetime of a
patient would not be sufﬁcient to allow a trial of all the available
options,14 it can be stated that there is more than a lifetime supply
of AED combinations for all patients. For this reason, as well as the
success rates of AEDs noted by Kwan and Brodie, identiﬁcation of
the number of drug failures that deﬁne pharmacoresistance could
be an act of beneﬁcence, nonmaleﬁcence, and respect. Somepatients could be spared the risks from undergoing surgery and
some patients could be spared the risks of needless trials of various
drugs.
Benbadis and Tatum suggested that the number of AEDs that
should be tried before a patient is deemed medically intractable is
a matter of judgment.15 As noted in Table 1, despite the fact that
the majority of respondents agreed that two AED failures signify a
drug-resistant condition, nearly 20% of the physicians stated that
there are no minimum number of drugs that deﬁne pharmacore-
sistance and surgical candidacy. This suggests that these physi-
cians, along with those that might attempt more than two drugs,
may expose patients to harm by pursuing lengthy trials of drug
therapy with a minimal chance of seizure control. Concurrently, it
suggests the possibility that some physicians offer minimal drug
therapy.
Correlating one AED failure to pharmacoresistance and surgical
candidacy, as 3% of physicians did, can be viewed as nonmaleﬁcent,
since patients have not been given a fair opportunity to acquire
seizure control. Again, as Kwan and Brodie observed, almost half of
the patients fail to respond to the ﬁrst prescribed AED; yet, two-
thirds of patients with epilepsy respond to drug therapy.1 For these
reasons and for compliance with the principles of beneﬁcence,
nonmaleﬁcence, and respect, the neurology community should
consider formulating a consensus that deﬁnes pharmacoresistance
and determines TL eligibility.
4.2. Pre-surgical testing and surgical candidacy
Nearly 90% of the population is skilled primarily with their right
hand, and the left hemisphere is responsible for this ability.16
Similarly, language ability is dominant in the left hemisphere in
more than 95% of right-handed persons.16 For left-handed persons,
however, language dominance exists within the left hemisphere
only 70% of the time.16 For the 10% of the population who is left-
handed, language abilities are dominant in the right hemisphere
30% of the time. As previously noted, the Wada test identiﬁes the
dominant hemisphere, and approximately 10% of respondents
stated that only left-handed persons, right-handed persons who
present with a normal MRI, and/or patients suspected of having a
dominant right hemisphere qualify for the Wada test at their
institution. Patients who do not meet these criteria are often
assumed to be left hemisphere dominant and are not offered the
Wada test.
Ninety-eight percent of adult epileptologists and all adult
neurosurgeons stated that the Wada test is available at their
institution. While nineteen out of nineteen adult neurosurgeons
stated that they utilize this test preoperatively and the accuracy
rate of theWada is 98%,17 the test is not always offered due to risks
and complications including stroke, transient neuropathy, and
arterial spasms.18 Assuming hemisphere dominance on the basis of
handedness alone, however, can be risky and, therefore, raises
questions regarding the principles of beneﬁcence and nonmaleﬁ-
cence. As cited by Wieser, only 50% of patients whose seizures are
not adequately managed with AEDs are surgical candidates.19
Appropriate preoperative counseling entails verifying that patients
are suitable surgical candidates. For this reason and the purpose of
predicting the outcome of the surgery, patients are entitled to
complete medical evaluation.
Provided that they are available, neuropsychological testing,
fMRI, and MEG, the non-invasive dominant hemisphere-identify-
ing investigations, should be offered to more patients, especially
right-handed patients who are not always offered theWada test, as
noted by approximately 10% of adult epileptologists. When the
results of two non-invasive exams are combined, particularly those
of the fMRI andMEG, the accuracy tends to be equivalent to that of
the Wada test.20 When neuropsychological testing is carried out,
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freedom and postoperative psychiatric deterioration can often be
predicted as well.21 If cerebral dominance cannot be determined
from the results of a combination of non-invasive procedures,
however, then the Wada test should be considered, especially if
right hemisphere dominance is suspected and surgical candidacy is
as low as Wieser cites.
The availability of the non-invasive exams is often limited,
however, according to physicians. For this reason, if the Wada test
is the only dominant hemisphere-identifying test available, then it
should be offered to all appropriate patients. If insurance coverage
is the prohibiting factor to the access of the non-invasive exams,
the role of the patient’s advocate, the physician, is critical in
securing the medical services, as emphasized in some ways by
Kant, Thomas Percival, and deontological ethics.22 Thus, there may
be an opportunity to formulate evidence-based guidelines that
identify the necessary measures that should be carried out to
evaluate hemisphere dominance, determine surgical candidacy,
and predict surgical outcome.
Finally, there are various tests that are used to evaluate the
patient’s wellbeing. The Liverpool Seizure Severity Scale, epilepsy-
speciﬁc Quality of Life in Epilepsy Inventory-89, and Minnesota
Multiphasic Personality Inventory can evaluate seizure severity,
quality of life, and personality, respectively.21,23 Psychopathology
can be assessed with a general health questionnaire, while
depression can be evaluated with the depression scale of the
Center for Epidemiological Studies.23 Just as gastro-enterologists
use the score acquired from the Crohn’s Disease Activity Index as a
measure of disease severity and thus candidacy for surgery,24
epileptologists and neurosurgeons may consider following aTable 5
Most positive outcomes to convey to patients.
AEP
No. of survey respondents 60
No. of survey respondents who responded to question 22 46
Seizure freedom
No. 1 67.4% (31/46
Top 3 71.7% (33/46
Seizure reduction
No. 1 4.3% (2/46)
Top 3 4.3% (2/46)
Seizure freedom and seizure reduction
No. 1 19.6% (9/46)
Top 3 19.6% (9/46)
AED discontinuation
No. 1 0%
Top 3 4.3% (2/46)
AED reduction
No. 1 0%
Top 3 30.4% (14/46
AED discontinuation and AED reduction
No. 1 0%
Top 3 8.7% (4/46)
Improved quality of life/psychosocial outcome
No. 1 6.5% (3/46)
Top 3 78.3% (36/46
Improved cognitive/neuropsychological outcome
No. 1 2.2% (1/46)
Top 3 17.4% (8/46)
Improved safety and increased survival
No. 1 0%
Top 3 8.7% (4/46)
AEP: adult epileptologist, AED: antiepileptic drug, ANS: adult neurosurgeon, PEP: pedia
No. 1: most positive outcome of TL, Top 3: one of the three most positive outcomes ofsimilar approach and routinely use the scores acquired from these
exams to determine TL eligibility.
4.3. Informed consent and the ideal physician
The policy of informed consent is essential for decision-making
and has become a requirement by organizations such as the Joint
Commission on Accreditation of Healthcare Organization, as well
as some state statutes.25 Before patients receive any type of
treatment, the nature of the recommended treatment, its risks and
beneﬁts, alternative treatments, and the consequences of receiving
no treatment should be disclosed.25,26 Based on the practice
variations identiﬁed, however, it seems that some physicians
involved with TL may not always address the information needed
for quality informed consent. Instead, it appears that some
physicians may select information that will encourage the patient
to consent to the intervention.
As we observed, while 71.7% of adult epileptologists and 61.5%
of adult neurosurgeons focused on the freedom from seizures as a
signiﬁcant positive outcome to convey, only 41.3% of adult
epileptologists and 35.7% of adult neurosurgeons viewed post-
surgical seizure continuation as a signiﬁcant adverse outcome to
disclose to patients (Tables 5 and 6). Similarly, according to one
physician, some information, such as the long-term data regarding
the efﬁcacy of the surgical intervention, should be withheld out of
fear that patients will be dissuaded from undergoing surgery. As a
result of these paternalistic approaches, it can be argued that some
patients are being deprived of their autonomy and may have
unrealistic expectations with respect to the outcome of the
procedure.ANS PEP PNS
19 11 18
13 9 13
) 61.5% (8/13) 33.3% (3/9) 30.8% (4/13)
) 61.5% (8/13) 33.3% (3/9) 30.8% (4/13)
15.4% (2/13) 11.1% (1/9) 7.7% (1/13)
23.1% (3/13) 33.3% (3/9) 7.7% (1/13)
15.4% (2/13) 22.2% (2/9) 46.2% (6/13)
15.4% (2/13) 33.3% (3/9) 46.2% (6/13)
0% 0% 0%
0% 11.1% (1/9) 7.7% (1/13)
0% 0% 0%
) 15.4% (2/13) 11.1% (1/9) 15.4% (2/13)
0% 0% 0%
15.4% (2/13) 33.3% (3/9) 0%
7.7% (1/13) 33.3% (3/9) 0%
) 53.9% (7/13) 100% (9/9) 53.9% (7/13)
0% 0% 7.7% (1/13)
15.4% (2/13) 0% 38.5% (5/13)
0% 0% 7.7% (1/13)
23.1% (3/13) 0% 7.7% (1/13)
tric epileptologist, and PNS: pediatric neurosurgeon.
TL.
Table 6
Most adverse outcomes to convey to patients.
AEP ANS PEP PNS
No. of survey respondents 60 19 11 18
No. of survey respondents who responded to question 23 46 14 9 15
Surgical risks/complications (acute or chronic)
No. 1 2.2% (1/46) 0% 0% 0%
Top 3 8.7% (4/46) 7.1% (1/14) 22.2% (2/9) 6.7% (1/15)
Acute issues (bleeding, clot, CVA, death, headache, infection, etc.)
No. 1 10.9% (5/46) 0% 0% 26.7% (4/15)
Top 3 30.4% (14/46) 28.6% (4/14) 11.1% (1/9) 33.3% (5/15)
Lack of seizure freedom and/or lack of seizure reduction
No. 1 30.4% (14/46) 28.6% (4/14) 33.3% (3/9) 20.0% (3/15)
Top 3 41.3% (19/46) 35.7% (5/14) 66.7% (6/9) 46.7% (7/15)
Memory/cognitive deﬁcitsa
No. 1 39.1% (18/46) 35.7% (5/14) 44.4% (4/9) 13.3% (2/15)
Top 3 84.8% (39/46) 78.6% (11/14) 88.9% (8/9) 53.3% (8/15)
Psychiatric/mood changesa
No. 1 6.5% (3/46) 0% 0% 0%
Top 3 28.2% (13/46) 21.4% (3/14) 33.3% (3/9) 20.0% (3/15)
Language/speech deﬁcits
No. 1 8.7% (4/46) 0% 33.3% (3/9) 20.0% (3/15)
Top 3 39.1% (18/46) 14.3% (2/14) 55.6% (5/9) 46.7% (7/15)
Visual deﬁcits
No. 1 4.3% (2/46) 14.3% (2/14) 0% 20.0% (3/15)
Top 3 21.7% (10/46) 42.9% (6/14) 11.1% (1/9) 46.7% (7/15)
New neurological deﬁcits (general)
No. 1 0% 0% 0% 0%
Top 3 10.9% (5/46) 14.3% (2/14) 0% 0%
New neurological deﬁcits (hemiplegia, hemiparesis, paralysis, etc.)
No. 1 0% 21.4% (3/14) 0% 0%
Top 3 0% 35.7% (5/14) 11.1% (1/9) 6.7% (1/15)
AEP: adult epileptologist, ANS: adult neurosurgeon, PEP: pediatric epileptologist, and PNS: pediatric neurosurgeon.
No. 1: most adverse outcome of TL, Top 3: one of the three most adverse outcomes of TL.
a Responses such as neuropsychological deﬁcit’’ were incorporated into both categories.
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their procedure are more likely to understand and have a higher
recall regarding their procedure.25 Furthermore, patients who
receive information through a structured interview, tend to feel
more involved with their treatment decision.25 Botrell et al. has
suggested that informed consent forms may facilitate a more
comprehensive dialogue between the patient and physician.25 A
patient’s needs are likely to receivemore attention. For this reason,
epileptologists and neurosurgeons involved with TL should
consider constructing and formally reviewing with patients a
structured, detailed informed consent form that describes TL and
its likely beneﬁts and risks. Including the risks and beneﬁts of no
surgery on the informed consent document would also be
appropriate.
In addition to providing thorough informed consent forms,
offering the appropriate preoperative testing would seem to be
essential for full informed consent. These procedures would allow
patients to have information that directly relates to them. Access to
this information, in addition to general information, could very
well assist with decision-making, provide patients with security,
and recognize the principle of autonomy based on full information
for all patients.
4.4. Speciﬁc information disclosed by speciﬁc physicians
Based on the data, it appears that each group of physicians
focuses on conveying speciﬁc information. As previously men-
tioned, epileptologists appear to discuss postoperative AED
management ten times more than neurosurgeons (Table 5).
Additionally, epileptologists are also more than twice as likelyto discuss postoperative quality of life and psychosocial outcome
(Table 5). Neurosurgeons, however, are almost twice as likely to
discuss the acute risks of the surgical procedure (Table 5). A clear
understanding of which provider has the responsibility for
conveying speciﬁc information is therefore essential. However,
both groups should be responsible for seeing that major risks and
beneﬁts, including the essential information relating to the
procedure and postoperative life, have been conveyed prior to
the surgery. In this way, the informed consent process is followed,
expectations by the patient are not as high, and success may even
be likely to increase.
For example, patients who continue AEDs postoperatively, are
more likely to remain in remission. Schiller et al. observed that 14%
and 36% of patients who were free from seizures postoperatively
relapsed within two and ﬁve years of AED withdrawal.27 If
physicians did not counsel patients on the importance of
postoperative AED therapy, the percentage of patients remaining
in remission would most likely be signiﬁcantly lower. Although, if
more physicians counseled patients on this issue, it is possible that
the percentage of epileptologists reporting the importance of AEDs
as a common misunderstanding would be less than the majority.
Additionally, the basic bioethical principles, as well as informed
consent, would be honored to a greater degree.
5. Conclusion
The results of this survey suggest that there may be
opportunities for a more uniform approach to the management
of epilepsy which does not respond to medication. A sizeable
majority of physicians involved in the surgical treatment of
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Disseminating this concept to the broader community of providers
involved in themanagement of epilepsy and developing a standard
deﬁnition of pharmacoresistance could reduce the harm done to
patients in the pursuit of pharmacological treatments with little
likelihood of success.
With respect to the processes of assessing surgical candidacy
and of providing informed consent for TL, there appear to be
inconsistencies which may compromise patient autonomy. The
development of evidence-based consensus guidelines regarding
the risks and beneﬁts of various pre-surgical tests could ensure
that all patients are appropriately evaluated.
Providing informed consent forms that state the risks and
beneﬁts of the surgical intervention, in addition to having a formal
dialogue with patients regarding the procedure, may prevent
patients from having unrealistic expectations and postoperative
confusion. This approach may also maintain a quality doctor–
patient relationship and allow physicians to honor the bioethical
principles of medicine.
Dupont et al. discovered that while 92% of patients did not
regret their decision of undergoing surgery, 9% were dissatisﬁed as
a result of postoperative deﬁcits such as hemianopsia, memory
disturbances, and motor deﬁcits.2 At the same time, however, the
dissatisﬁed patients were free from seizures. Thus, based on the
data from our study and the data presented in Dupont et al., it
would be useful to know if the outcome that patients are
experiencing was adequately discussed before a decision of
undergoing surgery was made.
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Appendix A
1. How often does seizure onset in the dominant hemisphere
prohibit candidacy for temporal lobectomy for patients with
temporal lobe epilepsy?
Frequently
Infrequently
Virtually Never
2. In as detailed a manner as possible, discuss how you evaluate
hemisphere dominance and function prior to performing temporal
lobectomy. (Please consider all populations, including infants if
applicable to your practice, and state and describe whether protocols
vary according to population.)
3. In addition to standard temporal lobe resections, does your
center offer selective amygdalohippocampectomy to the population
(adult or pediatric) to whom you primarily provide your services?
Yes
No
4. Does your institution view a normalMRI as a contraindication to
temporal lobe resection?
Yes
No
5. Are there a minimum number of drug failures that your center
uses to deﬁne pharmacoresistance and surgical candidacy? (Pleaseexclude cases associated with focal dysplasia, mass lesions, and
vascular lesions in your response.)
There are no minimum number of drug failures which deﬁne
pharmacoresistance and surgical candidacy.
Yes, one drug failure deﬁnes pharmacoresistance and surgical
candidacy.
Yes, two drug failures deﬁne pharmacoresistance and surgical
candidacy.
Other (Please specify.)
6. Which postoperative seizure-free interval do you feel deﬁnes a
successful outcome of standard temporal lobe resection for intract-
able epilepsy?
At least a year
At least 5 years
At least 10 years
Lifespan only
Other (Please specify.)
7. Do you feel the seizure-free interval chosen in question 6 should
be considered as a cure or as a prolonged remission? Please explain
your reasoning.
8. The literature states that approximately 80% of patients
experience no seizures throughout the ﬁrst 1–3 years of post-surgical
life and that after 10 years, about 55% of patients are seizure-free.
In what detail do you discuss, with your patients and/or their
parents/legal guardians, the likelihood of a seizure-free life after
temporal lobectomy?
Do you feel patients and/or their parents/legal guardians should or
should not be presented with the above data? Please explain your
choice.
9. Assuming the patient is a surgical candidate, approximately
how much time do you, the physician, spend discussing the
advantages and disadvantages of temporal lobe resection before
the procedure is performed?
10. If other professionals are involved with the preoperative
counseling, what roles do they play? (Please include ethicists,
neuropsychologists, social workers, etc., if relevant. If no other
professionals are involved, simply state.)
11. In as detailed a manner as possible, please state four of the
most signiﬁcant topics you, the physician, discuss with patients
during preoperative counseling?
12. Is/are the caregiver(s) of patients of all ages provided with
preoperative counseling?
Yes
No
13. If preoperative counseling is not provided to the patient’s
caregiver(s), please explain why. (If preoperative counseling is
provided, simply state.)
14. If you do provide the caregivers of patients of all ages with
preoperative counseling, is it during a joint meeting and in the
presence of the patient or during a separate meeting?
The patient’s caregiver(s) receives/receive preoperative counsel-
ing during a joint meeting.
The patient’s caregiver(s) receives/receive preoperative counsel-
ing during a separate meeting.
The patient’s caregiver(s) does/do not receive preoperative
counseling.
15. If you provide the patient’s caregiver(s) with preoperative
counseling during a separate meeting, please state if the information
provided to the caregiver(s) is the same as that provided to the
patient. Please list any additional information thatmay be provided or
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caregiver(s) with preoperative counseling, simply state.)
16. If you work with pediatric patients with temporal lobe
epilepsy and have these patients participate in the surgical decision-
making process, at what age do you begin to include them in the
process? (If your pediatric patients do not participate in the decision-
making process or if the pediatric population is not applicable to your
practice, simply state.)
17. On a scale of 1–4, where 1 indicates unnecessary and 4
indicates essential, how do you view conducting a Wada test prior to
temporal lobectomy?
1 2 3 4
18. On a scale of 1–4, where 1 indicates unimportant and 4
indicates highly important, how important do you ﬁnd conducting a
PET scan prior to temporal lobectomy?
1 2 3 4
19. On a scale of 1–4, where 1 indicates unimportant and 4
indicates highly important, how important do you ﬁnd conducting a
SPECT scan prior to temporal lobectomy?
1 2 3 4
20. Do you routinely counsel patients and/or their parents/legal
guardians on potential neuropsychological deﬁcits that may arise
from resection?
Yes
No
21. For what reasons do you or do you not counsel patients and/or
their parents/legal guardians on the potential neuropsychological
deﬁcits that may result from resection?
22.With themost important outcome listed ﬁrst, rank in order the
three most positive outcomes of temporal lobectomy which you feel
should be conveyed to patients and/or their parents/legal guardians.
23.With themost important outcome listed ﬁrst, rank in order the
three most common adverse outcomes of temporal lobectomy which
you feel should be conveyed to patients and/or their parents/legal
guardians.
24. Are your patients and/or their parents/legal guardians
routinely warned of the potential adverse outcomes listed in the
response for question 23?
Yes
No
25. How do you view the value of seizure eradication in
comparison to quality of life (driving a motor vehicle, acquiring a
quality and even professional education, maintaining employment,
forming stable relationships, etc.)?
More Important
Equally Important
Less Important
26. In follow-up visits, what are the most common misunder-
standings you have found patients who have undergone temporal
lobectomy and/or their parents/legal guardians to have experienced?References
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